The equilibrium and kinetic drug binding properties of the mouse P-gp1a and P-gp1b P-glycoproteins are similar

被引:15
|
作者
Taylor, JC
Ferry, DR
Higgins, CF
Callaghan, R [1 ]
机构
[1] Univ Oxford, Nuffield Dept Clin Biochem & Cellular Sci, John Radcliffe Hosp, Oxford OX3 9DU, England
[2] Queen Elizabeth Hosp, Dept Clin Oncol, Birmingham B15 2TH, W Midlands, England
[3] Univ London Imperial Coll Sci Technol & Med, Sch Med, MRC, Ctr Clin Sci,Hammersmith Hosp, London, England
关键词
P-glycoprotein; MDR; drug binding; steroid hormones;
D O I
10.1038/sj.bjc.6690764
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The gene encoding the multidrug resistance P-glycoprotein (P-gp) is duplicated in rodent species and the functional basis for this remains unresolved. Despite a high sequence similarity, the mouse P-gp1a and P-gp1b isoforms show distinct patterns of tissue distribution which suggest a specific role of the P-gp1b isoform in steroid transport. In the present study possible biochemical differences between the isoforms were directly investigated at the level of drug interaction. There was no detectable difference in the affinity or binding capacity of the two isoforms towards [H-3]vinblastine at equilibrium. Similarly, the rate at which [H-3]vinblastine associates with P-gp was indistinguishable between the two isoforms. Some modest differences were observed in the relative abilities of the multidrug-resistant (MDR) reversing agents CP100-356, nicardipine and verapamil to displace equilibrium [H-3]vinblastine binding to P-gp1a and P-gp1b. The steroid hormone progesterone displayed a low affinity (K-i = 1.2 +/- 0.2 mu M for P-gp1a and 3.5 +/- 0.5 mu M for P-gp1b), suggesting an unlikely role as a physiological substrate. Thus the mouse isoforms do not appear to exhibit functional differences at the level of initial substrate interaction with protein. (C) 1999 Cancer Research Campaign.
引用
收藏
页码:783 / 789
页数:7
相关论文
共 50 条
  • [1] The equilibrium and kinetic drug binding properties of the mouse P-gp1a and P-gp1b P-glycoproteins are similar
    J C Taylor
    D R Ferry
    C F Higgins
    R Callaghan
    British Journal of Cancer, 1999, 81 : 783 - 789
  • [2] INVOLVEMENT OF p-GP AND MRP1 IN TRANSDERMAL DRUG PERMEATION
    Ito, Katsuaki
    Nguyen, Hai Thien
    Kato, Yukio
    Kubo, Yoshiyuki
    Tsuji, Akira
    DRUG METABOLISM REVIEWS, 2007, 39 : 179 - 180
  • [3] Effects of BCRP and P-gp Modulators on the Penetration of Aflatoxin B1 into the Mouse Brain
    Tras, Bunyamin
    Cetin, Gul
    Uney, Kamil
    Dik, Burak
    Corum, Orhan
    Atalay, Sema
    KAFKAS UNIVERSITESI VETERINER FAKULTESI DERGISI, 2017, 23 (01) : 95 - 100
  • [4] Species difference of P-gp mediated drug transport across P-gp expressed LLC-PK1 cell monolayers
    Adachi, Y
    Guiney, D
    Ninomiya, S
    Sudo, T
    DRUG METABOLISM REVIEWS, 2003, 35 : 153 - 153
  • [5] PH AND MAGNESIUM(MG) ALTER 45 CALCIUM(CA) BINDING TO HUMAN PLATELETS(P), BUT AT SITES OTHER THAN GLYCOPROTEINS-1, OR GLYCOPROTEIN-11B, GLYCOPROTEIN-111A (GP-1, GP-11B, GP-111A)
    PEERSCHKE, EIB
    CLINICAL RESEARCH, 1984, 32 (02): : A319 - A319
  • [6] A LEPTOMYCIN-B RESISTANCE GENE OF SCHIZOSACCHAROMYCES-POMBE ENCODES A PROTEIN SIMILAR TO THE MAMMALIAN P-GLYCOPROTEINS
    NISHI, K
    YOSHIDA, M
    NISHIMURA, M
    NISHIKAWA, M
    NISHIYAMA, M
    HORINOUCHI, S
    BEPPU, T
    MOLECULAR MICROBIOLOGY, 1992, 6 (06) : 761 - 769
  • [7] The effect of P-gp (Mdr1a/1b), BCRP (Bcrp1) and P-gp/BCRP inhibitors on the in vivo absorption, distribution, metabolism and excretion of imatinib
    Oostendorp, Roos L.
    Buckle, Tessa
    Beijnen, Jos H.
    van Tellingen, Olaf
    Schellens, Jan H. M.
    INVESTIGATIONAL NEW DRUGS, 2009, 27 (01) : 31 - 40
  • [8] The effect of P-gp (Mdr1a/1b), BCRP (Bcrp1) and P-gp/BCRP inhibitors on the in vivo absorption, distribution, metabolism and excretion of imatinib
    Roos L. Oostendorp
    Tessa Buckle
    Jos H. Beijnen
    Olaf van Tellingen
    Jan H. M. Schellens
    Investigational New Drugs, 2009, 27 : 31 - 40
  • [9] Stereoselective transport of hydrophilic quaternary drugs by human MDR1 and rat Mdr1b P-glycoproteins
    Hooiveld, GJEJ
    Heegsma, J
    van Montfoort, JE
    Jansen, PLM
    Meijer, DKF
    Müller, M
    BRITISH JOURNAL OF PHARMACOLOGY, 2002, 135 (07) : 1685 - 1694
  • [10] P-glycoprotein (P-gp/MDR1)-mediated efflux of sex-steroid hormones and modulation of P-gp expression in vitro
    Kim, WY
    Benet, LZ
    PHARMACEUTICAL RESEARCH, 2004, 21 (07) : 1284 - 1293